QUEST DIAGNOSTICS INCDGX

Market cap
$22.8B
P/E ratio
Dec 31,
2010
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income7575065928835927536968247889061,4992,0801,015908921
Depreciation and amortization254281287283314304249270309329361408437439493
Provision for credit losses292280269270296297308315611194315
Deferred Income Tax Expense (Benefit)-192971923112379731585-571-4913
Stock-based compensation expense547250285152697961569779777788
Other, net--98-212-666-8398163-66-41-15
Accounts receivable----3122623432986563455-81-2461571
Accounts payable and accrued expenses18-18-13-2168-3156-8-197345235-149-55-67
Income taxes payable3439101-93-84-41421642922-20-31-216
Other assets and liabilities, net16-15811-241-2526-314379-537379
Net cash provided by operating activities1,1188951,1876529388101,0691,1751,2001,2432,0052,2331,7181,2721,334
Business acquisitions, net of cash acquired-1,2995121372867139581421583303311446112,164
Capital expenditures205162182231308263293252383400418403404408425
Other investing activities, net11-3-16-2-11-1-10-2-144273-542-41
Net cash used in investing activities-217-1,243-217328-1,025-362-152-805-801-411-77221-543-1,061-2,548
Proceeds from borrowings--7158962,0182,4531,8692052,0902,281749--2,5921,846
Repayments of debt-169-1,7101,3699001,6472,5371,7241821,9661,4491,554221,844303
Purchases of treasury stock7509352001,0371322245904653223533252,1991,408275151
Exercise of stock options49137162138786073130991191891291237273
Employee payroll tax withholdings on stock issued under stock-based compensation plans------102321161522282824
Dividends paid7165108185187212223247266286297309305314331
Distributions to noncontrolling interest partners373638323142415154545899735747
Other financing activities, net-8-221210-7-22-454023-1744-38-391421
Net cash provided by (used in) financing activities-98664-822-1,10692-507-691-592-401225-1,267-2,540-1,7321601,084
Effect of exchange rate changes on cash and cash equivalents and restricted cash---------------7
Net change in cash and cash equivalents and restricted cash-------------371-137